Drug Manufacturers - Specialty & Generic
Compare Stocks
2 / 10Stock Comparison
COSM vs NTRB
Revenue, margins, valuation, and 5-year total return — side by side.
Biotechnology
COSM vs NTRB — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Drug Manufacturers - Specialty & Generic | Biotechnology |
| Market Cap | $11M | $46M |
| Revenue (TTM) | $60M | $2M |
| Net Income (TTM) | $-19M | $-8M |
| Gross Margin | 11.4% | 24.9% |
| Operating Margin | -23.9% | -408.4% |
| Total Debt | $12M | $210K |
| Cash & Equiv. | $315K | $5M |
COSM vs NTRB — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Oct 21 | May 26 | Return |
|---|---|---|---|
| Cosmos Health Inc. (COSM) | 100 | 8.5 | -91.5% |
| Nutriband Inc. (NTRB) | 100 | 70.6 | -29.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: COSM vs NTRB
Each card shows where this stock fits in a portfolio — not just who wins on paper.
COSM carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 1 yrs, beta 1.72, yield 92.4%
- Rev growth 2.0%, EPS growth 45.6%, 3Y rev CAGR -1.1%
- 37.8% 10Y total return vs NTRB's -34.0%
NTRB is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta 1.20, Low D/E 3.1%, current ratio 6.36x
- Beta 1.20, current ratio 6.36x
- Beta 1.20 vs COSM's 1.72, lower leverage
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 2.0% revenue growth vs NTRB's -4.8% | |
| Quality / Margins | -31.0% margin vs NTRB's -404.1% | |
| Stability / Safety | Beta 1.20 vs COSM's 1.72, lower leverage | |
| Dividends | 92.4% yield; 1-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | -17.0% vs NTRB's -34.4% | |
| Efficiency (ROA) | -26.7% ROA vs NTRB's -101.9%, ROIC -28.9% vs -270.2% |
COSM vs NTRB — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
COSM vs NTRB — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
COSM leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
COSM is the larger business by revenue, generating $60M annually — 29.4x NTRB's $2M. Profitability is closely matched — net margins range from -31.0% (COSM) to -4.0% (NTRB). On growth, COSM holds the edge at +37.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $60M | $2M |
| EBITDAEarnings before interest/tax | -$13M | -$8M |
| Net IncomeAfter-tax profit | -$19M | -$8M |
| Free Cash FlowCash after capex | -$10M | -$5M |
| Gross MarginGross profit ÷ Revenue | +11.4% | +24.9% |
| Operating MarginEBIT ÷ Revenue | -23.9% | -4.1% |
| Net MarginNet income ÷ Revenue | -31.0% | -4.0% |
| FCF MarginFCF ÷ Revenue | -17.2% | -2.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +37.9% | -37.6% |
| EPS Growth (YoY)Latest quarter vs prior year | +62.2% | +84.4% |
Valuation Metrics
COSM leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $11M | $46M |
| Enterprise ValueMkt cap + debt − cash | $23M | $42M |
| Trailing P/EPrice ÷ TTM EPS | -0.30x | -1.47x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | 0.20x | 22.66x |
| Price / BookPrice ÷ Book value/share | 0.27x | 6.61x |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
COSM leads this category, winning 5 of 8 comparable metrics.
Profitability & Efficiency
COSM delivers a -80.1% return on equity — every $100 of shareholder capital generates $-80 in annual profit, vs $-118 for NTRB. NTRB carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to COSM's 0.48x.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -80.1% | -118.3% |
| ROA (TTM)Return on assets | -26.7% | -101.9% |
| ROICReturn on invested capital | -28.9% | -2.7% |
| ROCEReturn on capital employed | -44.3% | -125.5% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 3 |
| Debt / EquityFinancial leverage | 0.48x | 0.03x |
| Net DebtTotal debt minus cash | $12M | -$4M |
| Cash & Equiv.Liquid assets | $315,105 | $5M |
| Total DebtShort + long-term debt | $12M | $209,629 |
| Interest CoverageEBIT ÷ Interest expense | -9.42x | -369.11x |
Total Returns (Dividends Reinvested)
NTRB leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NTRB five years ago would be worth $6,603 today (with dividends reinvested), compared to $547 for COSM. Over the past 12 months, COSM leads with a -17.0% total return vs NTRB's -34.4%. The 3-year compound annual growth rate (CAGR) favors NTRB at 3.5% vs COSM's -52.8% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -32.0% | -14.4% |
| 1-Year ReturnPast 12 months | -17.0% | -34.4% |
| 3-Year ReturnCumulative with dividends | -89.5% | +10.8% |
| 5-Year ReturnCumulative with dividends | -94.5% | -34.0% |
| 10-Year ReturnCumulative with dividends | +37.8% | -34.0% |
| CAGR (3Y)Annualised 3-year return | -52.8% | +3.5% |
Risk & Volatility
NTRB leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
NTRB is the less volatile stock with a 1.20 beta — it tends to amplify market swings less than COSM's 1.72 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NTRB currently trades 32.4% from its 52-week high vs COSM's 26.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.72x | 1.20x |
| 52-Week HighHighest price in past year | $1.32 | $11.68 |
| 52-Week LowLowest price in past year | $0.28 | $3.42 |
| % of 52W HighCurrent price vs 52-week peak | +26.5% | +32.4% |
| RSI (14)Momentum oscillator 0–100 | 48.6 | 50.8 |
| Avg Volume (50D)Average daily shares traded | 793K | 11K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
COSM is the only dividend payer here at 92.44% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — |
| Price TargetConsensus 12-month target | — | — |
| # AnalystsCovering analysts | — | — |
| Dividend YieldAnnual dividend ÷ price | +92.4% | — |
| Dividend StreakConsecutive years of raises | 1 | 1 |
| Dividend / ShareAnnual DPS | $0.32 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
COSM leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). NTRB leads in 2 (Total Returns, Risk & Volatility).
COSM vs NTRB: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is COSM or NTRB a better buy right now?
For growth investors, Cosmos Health Inc.
(COSM) is the stronger pick with 2. 0% revenue growth year-over-year, versus -4. 8% for Nutriband Inc. (NTRB). The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — COSM or NTRB?
Over the past 5 years, Nutriband Inc.
(NTRB) delivered a total return of -34. 0%, compared to -94. 5% for Cosmos Health Inc. (COSM). Over 10 years, the gap is even starker: COSM returned +37. 8% versus NTRB's -34. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — COSM or NTRB?
By beta (market sensitivity over 5 years), Nutriband Inc.
(NTRB) is the lower-risk stock at 1. 20β versus Cosmos Health Inc. 's 1. 72β — meaning COSM is approximately 43% more volatile than NTRB relative to the S&P 500. On balance sheet safety, Nutriband Inc. (NTRB) carries a lower debt/equity ratio of 3% versus 48% for Cosmos Health Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — COSM or NTRB?
By revenue growth (latest reported year), Cosmos Health Inc.
(COSM) is pulling ahead at 2. 0% versus -4. 8% for Nutriband Inc. (NTRB). On earnings-per-share growth, the picture is similar: Cosmos Health Inc. grew EPS 45. 6% year-over-year, compared to -160. 6% for Nutriband Inc.. Over a 3-year CAGR, NTRB leads at -0. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — COSM or NTRB?
Cosmos Health Inc.
(COSM) is the more profitable company, earning -29. 7% net margin versus -404. 1% for Nutriband Inc. — meaning it keeps -29. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: COSM leads at -28. 6% versus -408. 4% for NTRB. At the gross margin level — before operating expenses — NTRB leads at 25. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — COSM or NTRB?
In this comparison, COSM (92.
4% yield) pays a dividend. NTRB does not pay a meaningful dividend and should not be held primarily for income.
07Is COSM or NTRB better for a retirement portfolio?
For long-horizon retirement investors, Cosmos Health Inc.
(COSM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (92. 4% yield). Both have compounded well over 10 years (COSM: +37. 8%, NTRB: -34. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between COSM and NTRB?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: COSM is a small-cap income-oriented stock; NTRB is a small-cap quality compounder stock. COSM pays a dividend while NTRB does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.